-
1
-
-
0001639195
-
Some speculations on the myeloproliferative syndromes
-
Damashek W. Some speculations on the myeloproliferative syndromes. Blood 1951;6:372-5.
-
(1951)
Blood
, vol.6
, pp. 372-375
-
-
Damashek, W.1
-
2
-
-
32144453842
-
JAK/STAT signal transduction : Regulators and implication in haematological malignancies
-
Valentino L, Pierre J. JAK/STAT signal transduction : regulators and implication in haematological malignancies. Biochemical Pharmacology 2006;71:713-21.
-
(2006)
Biochemical Pharmacology
, vol.71
, pp. 713-721
-
-
Valentino, L.1
Pierre, J.2
-
3
-
-
33746043322
-
The role of Janus kinases in haemopoiesis and haematological malignancy
-
Khwaja A. The role of Janus kinases in haemopoiesis and haematological malignancy. Br J Haematol 2006;134:366-84.
-
(2006)
Br J Haematol
, vol.134
, pp. 366-384
-
-
Khwaja, A.1
-
4
-
-
0020972981
-
Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukaemia
-
Bartram C, de Klein A, Hagemeijer A. Translocation of c-abl oncogene correlates with the presence of the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983;306:277-280.
-
(1983)
Nature
, vol.306
, pp. 277-280
-
-
Bartram, C.1
de Klein, A.2
Hagemeijer, A.3
-
5
-
-
20144363192
-
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
-
Baxter EJ, Scott LM, Camphell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;365:1054-61.
-
(2005)
Lancet
, vol.365
, pp. 1054-1061
-
-
Baxter, E.J.1
Scott, L.M.2
Camphell, P.J.3
-
6
-
-
17844383458
-
A unique clonal JAK2 mutations leading to constitutive signaling causes polycythemia vera
-
James C, Ugo V, Le Couedic, et al. A unique clonal JAK2 mutations leading to constitutive signaling causes polycythemia vera. Nature 2005;434:1144-8.
-
(2005)
Nature
, vol.434
, pp. 1144-1148
-
-
James, C.1
Ugo, V.2
Couedic, L.3
-
7
-
-
17644424955
-
A gain-of-functions mutation of JAK2 is myeloproliferative disorders
-
Kralovics R, Passamonti F, Buser AS et al. A gain-of-functions mutation of JAK2 is myeloproliferative disorders. N Eng J Med 2005;352:1779-90.
-
(2005)
N Eng J Med
, vol.352
, pp. 1779-1790
-
-
Kralovics, R.1
Passamonti, F.2
Buser, A.S.3
-
8
-
-
20244369569
-
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis
-
Levine RL, Wedleigh M, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. Cancer Cell 2005;7:387-97.
-
(2005)
Cancer Cell
, vol.7
, pp. 387-397
-
-
Levine, R.L.1
Wedleigh, M.2
-
9
-
-
20744460045
-
identification of an acquired JAK2 mutation in polycythemia vera
-
Zhao R, Xing S, et al. identification of an acquired JAK2 mutation in polycythemia vera. Journal of Biol Chem 2005;280:22788-92.
-
(2005)
Journal of Biol Chem
, vol.280
, pp. 22788-22792
-
-
Zhao, R.1
Xing, S.2
-
10
-
-
34347401112
-
-
V617F mutation in familial myeloproliferative disorders. Program and abstracts of the 2005 American Society of Haematology Annual Meeting and Exposition : December 10-13, 2005; Atlanta, Georgia. Abstract 115.
-
V617F mutation in familial myeloproliferative disorders. Program and abstracts of the 2005 American Society of Haematology Annual Meeting and Exposition : December 10-13, 2005; Atlanta, Georgia. Abstract 115.
-
-
-
-
11
-
-
34047236618
-
Markers of myeloproliferative disease in childhood polycythemia vera and essential thrombocythemia
-
Teofili L, Giona F, et al. Markers of myeloproliferative disease in childhood polycythemia vera and essential thrombocythemia. J Clin Oncol 2007;25:1048-53.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1048-1053
-
-
Teofili, L.1
Giona, F.2
-
12
-
-
33947541141
-
V617F activity and polycythemia vera cell growth
-
V617F activity and polycythemia vera cell growth. J Biol Chem 2007;282:3428-34.
-
(2007)
J Biol Chem
, vol.282
, pp. 3428-3434
-
-
Li, Z.1
Xu, N.2
|